Clinical Trial Update: A Study to Test Different Doses of BI 1569912 in People With Depression Who Take Anti-depressive Medicine [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating different doses of BI 1569912 in adults with major depressive disorder who are taking antidepressants has completed, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• BI 1569912

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Depressive Disorder, Major | Phase 2 | Status: COMPLETED | Results posted: 2026-03-27